Top 5 Stock Picks of Henrik Rhenman’s Rhenman Partners

3. AbbVie Inc. (NYSE:ABBV)

Rhenman Partners’ Stake Value:  $31,611,000

Percentage of Rhenman Partners’ 13F Portfolio: 3.11%

Number of Hedge Fund Holders: 76

AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company that discovers, develops, manufactures, and sells pharmaceuticals worldwide.

Securities filings for Q1 2022 reveal that Rhenman Partners added AbbVie Inc. (NYSE:ABBV) to its portfolio by purchasing 195,000 shares worth $31.6 million, representing 3.11% of the total 13F holdings.